Durata Therapeutics, Inc. Restricted Stock or Unit Expense
Durata Therapeutics, Inc. reported Restricted Stock or Unit Expense of $25.00 thousand for the 12-month period ending 2009-12-31, per its 10-K filed 2013-03-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestrictedStockExpense · last filed 2013-03-08
- Durata Therapeutics, Inc. restricted stock or unit expense for fiscal 2009 was $25.00K.
| Period end | Restricted Stock or Unit Expense 12 month |
|---|---|
| 2009-12-31 | $25.00K 10-K · filed 2013-03-08 |